EP1183266A4 - INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR - Google Patents

INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR

Info

Publication number
EP1183266A4
EP1183266A4 EP00941527A EP00941527A EP1183266A4 EP 1183266 A4 EP1183266 A4 EP 1183266A4 EP 00941527 A EP00941527 A EP 00941527A EP 00941527 A EP00941527 A EP 00941527A EP 1183266 A4 EP1183266 A4 EP 1183266A4
Authority
EP
European Patent Office
Prior art keywords
retro
peptides derived
inhibitory factor
leukemia inhibitory
inverso peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00941527A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1183266A1 (en
Inventor
David E Wright
D Elliot Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myelos Corp
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of EP1183266A1 publication Critical patent/EP1183266A1/en
Publication of EP1183266A4 publication Critical patent/EP1183266A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00941527A 1999-06-16 2000-06-16 INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR Withdrawn EP1183266A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968599P 1999-06-16 1999-06-16
US139685P 1999-06-16
PCT/US2000/016760 WO2000077029A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from leukemia inhibitory factor

Publications (2)

Publication Number Publication Date
EP1183266A1 EP1183266A1 (en) 2002-03-06
EP1183266A4 true EP1183266A4 (en) 2002-10-23

Family

ID=22487838

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00941527A Withdrawn EP1183266A4 (en) 1999-06-16 2000-06-16 INVERTED RETRO PEPTIDES DERIVED FROM LEUKEMIA INHBITION FACTOR

Country Status (6)

Country Link
EP (1) EP1183266A4 (enExample)
JP (2) JP2003502341A (enExample)
AU (1) AU5622700A (enExample)
CA (1) CA2376474A1 (enExample)
IL (2) IL147095A0 (enExample)
WO (1) WO2000077029A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
EP1267911A4 (en) * 2000-03-03 2004-04-21 Amrad Corp Ltd TREATMENT METHOD
AU3713201A (en) * 2000-03-03 2001-09-12 Inst Medical W & E Hall A method of treatment
CA2645245A1 (en) * 2006-03-31 2007-10-11 Queen's University At Kingston Compositions and methods for treating atherosclerosis
KR20180029201A (ko) 2015-05-18 2018-03-20 티씨알2 테라퓨틱스 인크. 융합 단백질을 이용하는 tcr 리프로그래밍을 위한 조성물 및 방법
JP7291396B2 (ja) 2016-11-22 2023-06-15 ティーシーアール２ セラピューティクス インク． 融合タンパク質を用いたｔｃｒの再プログラミングのための組成物及び方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (en) * 1997-03-05 2000-08-23 Univ California METHOD FOR HEALING NEUROPATHIC PAIN
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BRIAND JP ET AL.: "A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 94, November 1997 (1997-11-01), pages 12545 - 12550, XP002208543 *
CHOREV M & GOODMAN M: "Recent developments in retro peptides and proteins - an ongoing topochemical exploration", TRENDS IN BIOTECHNOLOGY, vol. 13, October 1995 (1995-10-01), pages 438 - 445, XP002208544 *
See also references of WO0077029A1 *

Also Published As

Publication number Publication date
IL147095A0 (en) 2002-08-14
IL147095A (en) 2010-12-30
AU5622700A (en) 2001-01-02
JP2003502341A (ja) 2003-01-21
CA2376474A1 (en) 2000-12-21
WO2000077029A1 (en) 2000-12-21
EP1183266A1 (en) 2002-03-06
JP2011144184A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
GB0128994D0 (en) Peptides
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
EP1534308A4 (en) PEPTIDES WITH INHIBITORY ACTION OF GROWTH
GB0100196D0 (en) Peptides
IL147095A (en) Retro-inverso peptides derived from leukemia inhibitory factor
GB9825854D0 (en) Peptide
EP1185558A4 (en) PEPTIDES WITH PREPTID FUNCTIONALITY
GB9904695D0 (en) Peptide
AU2973100A (en) Novel agouti and agouti-related peptide analogs
EP1147130A4 (en) ALPHA-conotoxin PEPTIDE
GB9812675D0 (en) Peptides
IL147093A0 (en) Retro-inverso peptides derived from interleukin-3
HK1042713A (en) Retro-inverso peptides derived from leukemia inhibitory factor
IL147094A0 (en) Retro-inverso peptides derived from interleukin-6
GB0120713D0 (en) Peptides
HK1042712A (en) Retro-inverso peptides derived from interleukin-6
GB9807890D0 (en) Peptides
HK1042711A (en) Retro-inverso peptides derived from interleukin-3
IL143950A0 (en) Polypeptides derived from jnk3
IL149355A0 (en) Polypeptide corporation
GB9907911D0 (en) Peptides
GB9918597D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides
GB9918604D0 (en) Novel peptides
GB9918606D0 (en) Novel peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020905

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030415

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030826

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1042713

Country of ref document: HK